Drug intelligence / Profile preview

V0355

Development stage: Discontinued
Modality: Small Molecules
Administration: Oral

Overview

V0355 is a prolonged-release oral formulation of ferrous sulphate, a small molecule. It is developed for the treatment of iron deficiency anemia, aiming to restore iron stores and hemoglobin levels. Clinical trials have investigated its pharmacokinetics and compared its efficacy and tolerability to other standard treatments like Ferrograd®.

Beyond the preview

Go deeper on V0355.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on V0355.

Explore the full profile